Avenue Therapeutics ATXI
OTC ATXI
$0.43 +0.00 (+0.00%)
At close: Oct 19, 2026 · 4:00 PM EDT

Avenue Therapeutics (ATXI) Revenue (2025)

Updated

Avenue Therapeutics' Revenue was $1.4 million in FY2025.

Analysis

Avenue Therapeutics (ATXI) Revenue (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Revenue (Qtr)
1 Eli Lilly 1,164.71 Bn 1,133.30 Bn 19.71 Bn 22.97 Bn
2 Johnson & Johnson 633.37 Bn 551.90 Bn 17.26 Bn 25.31 Bn
3 AbbVie 503.99 Bn 477.10 Bn 12.70 Bn 16.99 Bn
4 Merck 378.19 Bn 332.57 Bn 12.21 Bn 16.61 Bn
5 Novartis Ag 303.15 Bn 267.14 Bn 11.24 Bn 14.41 Bn
6 Astrazeneca 266.17 Bn 239.85 Bn 12.86 Bn 15.38 Bn
7 Amgen 241.38 Bn 196.78 Bn 7.24 Bn 10.05 Bn
8 Gilead Sciences 194.07 Bn 168.27 Bn 6.22 Bn 7.80 Bn
9 Pfizer 172.31 Bn 118.96 Bn 10.94 Bn 15.03 Bn
10 Avenue Therapeutics 1.42 Mn -9.51 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2025 1.40 Mn
API Access

Avenue Therapeutics Revenue API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=revenue&ticker=ATXI&period=max&api_key=YOUR_API_KEY